Analyst Conference Summaries

Biotechnology Investor Aids

Tetraphase Pharmaceuticals
TTPH

press release date: August 8, 2019 @ 1:30 PM Pacific Time

Biotech Bargain Basement: Tetraphase [January 2, 2019 at Seeking Alpha]

Tetraphase Pharmaceuticals, My Favorite 2H 2018 Biotech [May 23, 2018 at Seeking Alpha]

Tetraphase Pharmaceuticals Trial Failure May Mask Value [February 27, 2018 at Seeking Alpha]

2019
Tetraphase
Pharmaceuticals
Q1 2019

Tetraphase
Pharmaceuticals
Q2 2019

   
May 8, 2019 August 8, 2019    
2018
Tetraphase
Pharmaceuticals
Q4 2018
May 3, 2018
Aug. 2, 2018
Nov. 8, 2018
Mar. 14, 2019

Tetraphase Pharmaceuticals (TTPH) is a clinical-stage biotechnology company specializing in multidrug-resistant antibiotic therapies.

Tetraphase Pharmaceutical web site


 

Search

More Analyst Conference Pages:

 AGEN
 AGIO
 ALNY
 ALXN
 AMAT
 AMD
 AMGN
 BIIB
 CLDX
 CELG
 EPZM
 GILD
 GLYC
 INO
 INTC
 ISRG
 MCHP
 MYL.
 PLX
 REGN
 SGEN
 VBLT
 VSTM
 XLNX
 XLRN
 
 

Disclaimer: My analyst summaries may include both condensations of statements made by company representatives and my own analysis. They are not covered by any warranty. I cannot guarantee anything said by company representatives is true. I try not to make errors, but it is possible. These are my personal notes which I share with other investors and which I use as the basis of my blog and Seeking Alpha articles.

Copyright 2019 William P. Meyers